CHAPERONE-ASSISTED RNA CRYSTALLOGRAPHY - Resubmission 01
伴侣辅助 RNA 晶体学 - 重新提交 01
基本信息
- 批准号:8643797
- 负责人:
- 金额:$ 32.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAntibodiesAntibody FormationAntibody RepertoireAntigensAreaBackBedsBenchmarkingBindingBiologyCatalytic RNAChargeClear CellComplexCrystallizationCrystallographyDatabasesDevelopmentDiseaseEpitopesFab ImmunoglobulinsFamilyFunctional RNAFutureGenerationsGoalsHealthHigher Order Chromatin StructureHumanImmuneImmune systemIndividualKnowledgeLibrariesMediatingMolecular ChaperonesMolecular WeightNucleic AcidsNucleotidesPhage DisplayPhasePlayProbabilityProceduresProcessProductionProteinsRNARNA BindingRNA FoldingRNA Ligase (ATP)RNA analysisRNA-Binding ProteinsReagentRecombinantsResearchRibonucleoproteinsRoleSourceSpecificityStagingStructureSurfaceSystemTechnologyTestingTherapeuticTissuesVisionWorkbasechemical reactioncombinatorialdesigndesign and constructionfeedingfunctional grouphigh throughput technologyinorganic phosphatenext generationnovelnovel strategiesnucleic acid structureprotein complexprotein structurepublic health relevancestemstructural genomics
项目摘要
DESCRIPTION (provided by applicant): In the last decade it has become clear that the cell contains a greater diversity of functional RNAs than previously thought. Many of these RNAs fold back upon themselves to form higher order structures, catalyzing chemical reactions and interacting with proteins to mediate a plethora of other critical functions. Structural genomics initiatives have focused on protein structure and all but ignored nucleic acid structure. Of the nearly 60,000 structures in the Protein Data Bank fewer than 3% are nucleic acids. Given the obvious value of structure in understanding biology and disease and in developing therapeutic strategies, RNA structure determination cannot continue at its current pace, and future structural genomics initiatives must necessarily address this bottleneck. Achieving this goal is challenging because of the difficulties associated with obtaining high quality RNA crystals. These difficulties
stem in part from factors that confound lattice formation including the mutually repulsive negatively charged phosphates that decorate the surface of an RNA and the lack of diverse functional groups for mediating crystal contacts. In this application, we propose a potentially transformative approach to RNA crystallography in which we use recombinant Fab (antigen binding fragment) technology to develop an integrative pipeline for application of chaperone assisted RNA crystallography (CARC). Because traditional approaches for antibody production are not amenable to complex RNA targets, powerful immunomethods, including Fab assisted crystallography, have generally been orthogonal to RNA research. We will circumvent this problem by developing phage display libraries tailored for efficient generation of Fabs that bind to RNA, and we will use the Fabs to facilitate crystallization and structure determination of a selected test bed of high-hanging RNAs and ribonucleoprotein complexes (RNPs). Another major benefit from our efforts will be the development of a rich source of next-generation affinity
reagents for functional analysis of RNA and RNPs and novel "designer" RNA binding proteins.
描述(由申请人提供):在过去的十年中,已经清楚细胞含有比以前想象的更多的功能性RNA多样性。许多这些 RNA 自身折叠形成更高阶的结构,催化化学反应并与蛋白质相互作用以介导大量其他关键功能。结构基因组学计划主要关注蛋白质结构,而几乎忽略了核酸结构。在蛋白质数据库的近 60,000 个结构中,只有不到 3% 是核酸。鉴于结构在理解生物学和疾病以及制定治疗策略方面的明显价值,RNA结构测定无法以目前的速度继续下去,未来的结构基因组学计划必须解决这一瓶颈。实现这一目标具有挑战性,因为获得高质量 RNA 晶体存在困难。这些困难
部分源于扰乱晶格形成的因素,包括装饰RNA表面的相互排斥的带负电的磷酸盐以及缺乏介导晶体接触的多种官能团。在此应用中,我们提出了一种潜在的 RNA 晶体学变革方法,其中我们使用重组 Fab(抗原结合片段)技术来开发用于分子伴侣辅助 RNA 晶体学 (CARC) 应用的综合管道。由于传统的抗体生产方法不适用于复杂的 RNA 靶标,因此强大的免疫方法(包括 Fab 辅助晶体学)通常与 RNA 研究正交。我们将通过开发专门用于有效生成与 RNA 结合的 Fab 的噬菌体展示文库来规避这个问题,并且我们将使用 Fab 来促进选定的高悬 RNA 和核糖核蛋白复合物 (RNP) 测试床的结晶和结构测定。我们努力的另一个主要好处是开发下一代亲和力的丰富来源
用于 RNA 和 RNP 功能分析的试剂以及新型“设计”RNA 结合蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Anthony Piccirilli其他文献
Joseph Anthony Piccirilli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Anthony Piccirilli', 18)}}的其他基金
The VS Ribozyme: Catalytic Mechanism, Transition State Structure, and Evolution
VS 核酶:催化机制、过渡态结构和进化
- 批准号:
10305610 - 财政年份:2019
- 资助金额:
$ 32.37万 - 项目类别:
The VS Ribozyme: Catalytic Mechanism, Transition State Structure, and Evolution
VS 核酶:催化机制、过渡态结构和进化
- 批准号:
10061618 - 财政年份:2019
- 资助金额:
$ 32.37万 - 项目类别:
The VS Ribozyme: Catalytic Mechanism, Transition State Structure, and Evolution
VS 核酶:催化机制、过渡态结构和进化
- 批准号:
10582360 - 财政年份:2019
- 资助金额:
$ 32.37万 - 项目类别:
CHAPERONE-ASSISTED RNA CRYSTALLOGRAPHY - Resubmission 01
伴侣辅助 RNA 晶体学 - 重新提交 01
- 批准号:
8506004 - 财政年份:2013
- 资助金额:
$ 32.37万 - 项目类别:
CHAPERONE-ASSISTED RNA CRYSTALLOGRAPHY - Resubmission 01
伴侣辅助 RNA 晶体学 - 重新提交 01
- 批准号:
9037690 - 财政年份:2013
- 资助金额:
$ 32.37万 - 项目类别:
Chaperone-Assisted RNA Crystallography-Equipment Supplement
分子伴侣辅助 RNA 晶体学设备补充品
- 批准号:
9895189 - 财政年份:2013
- 资助金额:
$ 32.37万 - 项目类别:
The Catalytic Mechanism of Nuclear Premessenger RNA Splicing by the Spliceosome
剪接体对核前信使RNA剪接的催化机制
- 批准号:
8788330 - 财政年份:2010
- 资助金额:
$ 32.37万 - 项目类别:
Investigating the Catalytic Mechanism of the HDV Ribozyme
HDV 核酶催化机制的研究
- 批准号:
8465171 - 财政年份:2010
- 资助金额:
$ 32.37万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于酵母展示与自体持续突变的纳米抗体快速亲和力成熟技术研究
- 批准号:82204046
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于新抗原受体可变域的赭曲霉毒素A竞争物与VHH抗体互作的亲和力调控机制
- 批准号:32102067
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 32.37万 - 项目类别:
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
- 批准号:
10526155 - 财政年份:2023
- 资助金额:
$ 32.37万 - 项目类别:
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
开发用于常规生成正交 GPCR 靶向纳米抗体的集成管道
- 批准号:
10603669 - 财政年份:2023
- 资助金额:
$ 32.37万 - 项目类别: